• Mexico

Mexican Pharma Stocks Analysis

BMV:LAB B
BMV:LAB B
BMV:LAB BPharmaceuticals

Genomma Lab Internacional. de's (BMV:LABB) three-year earnings growth trails the shareholder returns

June 29, 2022
By buying an index fund, investors can approximate the average market return. But if you choose individual stocks with...
BMV:LAB B
BMV:LAB B
BMV:LAB BPharmaceuticals

Genomma Lab Internacional. de (BMV:LABB) Could Be A Buy For Its Upcoming Dividend

June 03, 2022
Readers hoping to buy Genomma Lab Internacional, S.A.B. de C.V. ( BMV:LABB ) for its dividend will need to make their...
BMV:LAB B
BMV:LAB B
BMV:LAB BPharmaceuticals

Could The Market Be Wrong About Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Given Its Attractive Financial Prospects?

May 03, 2022
With its stock down 5.2% over the past week, it is easy to disregard Genomma Lab Internacional. de (BMV:LABB). But if...
BMV:LAB B
BMV:LAB B
BMV:LAB BPharmaceuticals

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

March 22, 2022
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
BMV:LAB B
BMV:LAB B
BMV:LAB BPharmaceuticals

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

February 15, 2022
Does the February share price for Genomma Lab Internacional, S.A.B. de C.V. ( BMV:LABB ) reflect what it's really...
BMV:LAB B
BMV:LAB B
BMV:LAB BPharmaceuticals

How Much Of Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Do Insiders Own?

September 25, 2021
The big shareholder groups in Genomma Lab Internacional, S.A.B. de C.V. ( BMV:LABB ) have power over the company...
BMV:LAB B
BMV:LAB B
BMV:LAB BPharmaceuticals

Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

September 07, 2021
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
  • 1

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.